Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang-Hong Yin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Biomolecular Screening|March 12, 2011
Development of a high-throughput cell-based reporter assay for screening of JAK3 inhibitorsChang-Hong Yin, Erika A Bach, Gyeong-Hun Baeg
Molecular Cancer|February 13, 2010
NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3Byung-Hak Kim, Jun-Goo Jee, Chang-Hong Yin, et al.
British Journal of Pharmacology|March 26, 2011
Inhibition of the signalling kinase JAK3 alleviates inflammation in monoarthritic ratsByung-Hak Kim, Myunghwan Kim, Chang-Hong Yin, et al.
Molecular Cancer Therapeutics|September 16, 2008
A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cellsByung Hak Kim, Chang-Hong Yin, Qianxu Guo, et al.
British Journal of Haematology|October 2, 2009
MS-1020 is a novel small molecule that selectively inhibits JAK3 activityByung-Hak Kim, Sei-Ryang Oh, Chang-Hong Yin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Biomolecular Screening|March 12, 2011
Development of a high-throughput cell-based reporter assay for screening of JAK3 inhibitorsChang-Hong Yin, Erika A Bach, Gyeong-Hun Baeg
Molecular Cancer|February 13, 2010
NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3Byung-Hak Kim, Jun-Goo Jee, Chang-Hong Yin, et al.
British Journal of Pharmacology|March 26, 2011
Inhibition of the signalling kinase JAK3 alleviates inflammation in monoarthritic ratsByung-Hak Kim, Myunghwan Kim, Chang-Hong Yin, et al.
Molecular Cancer Therapeutics|September 16, 2008
A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cellsByung Hak Kim, Chang-Hong Yin, Qianxu Guo, et al.
British Journal of Haematology|October 2, 2009
MS-1020 is a novel small molecule that selectively inhibits JAK3 activityByung-Hak Kim, Sei-Ryang Oh, Chang-Hong Yin, et al.
Pageof 1